Business
Hop-on Subsidiary Re-Medical is Poised for Next Generation of Pain Killers
Hop-on Subsidiary Re-Medical is Poised for Next Generation of Pain Killers.
About this update from Hop-on, Inc.
[{"type":"text","content":"\n\n \n Re-Medical CBD for Next Generation of Pain Killers Delivered to World’s Sixth Largest Economy and Internationally  TEMECULA, CA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Hop-on, Inc. (OTC Pink: HPNN) announced today its subsidiary, Re-Medical, Inc., has set up distribution of cannabis-derived product offerings, secured a million dollar line of credit and is obtaining additional financing for expansion of operations.  Re-Medical has a variety of CBD and full-spectrum marijuana products for delivery to licensed facilities. In November this year, eight states passed new marijuana legalization. Beginning January 1st, 2018 California’s legal marijuana industry will take full effect. California has the sixth largest economy in the world, and according to the Los Angeles Times “California's new pot economy [is] valued at $7 billion.” Re-Medical has developed the “next generation” painkiller medication, with oral, transdermal, and injectable delivery of full-spectrum standardized formulations of cannabidiol (CBD) and/or tetrahydrocannabinol (THC) for pain related ailments. Phase 1 and Phase 2 testing of numerous cannabinoid pain treatments have already cleared the FDA.  Hundreds of millions of prescriptions for opioid painkillers were filled this last year – more than enough for every adult in the United States to take them for at least a month. Those numbers have built incredible wealth for the companies manufacturing these drugs, at the expense of the general public. Cannabinoid pain treatments can be just as effective as opioid-based medication, with a favorable safety profile, and without the addictive side effects. Re-Medical is licensing for production and distribution of the Company’s various revolutionary organic and solvent-free standardized cannabinoid formulations and products. Partnerships, technology licensing agreements, and distribution contracts are being offered to authorized marijuana cultivators, producers of infused products, medical marijuana facilities, and retailers in California, as well as other states and foreign jurisdictions. Re-Medical's mission is to provide solutions for patients to use cannabis as a nutraceutical alternative to traditional or prescription medications.   Re-Medical, Inc. is a Hop-on company focused on delivering...